Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dydrogesterone for Functional Ovarian Cysts
NCT03456570Phase 1Unknown
- Sponsor
- Assiut University
- Start
- May 2018
- Primary completion
- May 2020
- Modality
- Orthosteric Ligands
01
Overview
Phase 1, randomised trial in functional ovarian cyst comparing Dydrogesterone 10 mg twice daily with Placebo twice daily (2 arms). Primary endpoint: Disappearance of cyst at 2 months. Status: unknown.
02
Drugs
dydrogesterone
03
Conditions
functional ovarian cyst
Beyond the preview
Go deeper on NCT03456570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03456570.